Flavopiridol

Flavopiridol (Alvocidib) is a broad spectrum and competitive inhibitor of CDKs, inhibiting CDK1, CDK2, CDK4 with IC50s of 30, 170, 100 nM, respectively.

[1]Mahoney E, et al. ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.Blood. 2012 Aug 9;120(6):1262-1273.|[2]Keskin H, et al. Complex effects of flavopiridol on the expression of primary response genes. Cell Div. 2012 Mar 29;7:11.|[3]Kim KS, et al.Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. J Med Chem. 2000 Nov 2;43(22):4126-34.|[4]Jianliang Xu, et al. Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression. Cell Commun Signal. 2019 Jul 26;17(1):85.ACS Chem Biol. 2017 May 19;12(5):1245-1256.|Acta Pharm Sin B. 26 February 2022.|Biochem Biophys Res Commun. 2019 Jun 11;513(4):967-973.|Biomaterials. 2014 Aug;35(24):6585-94. |bioRxiv. 2023 Sep 7.|bioRxiv. 2024 July 27.|bioRxiv. 2024 Mar 17.|bioRxiv. 2024 Sep 29:2024.09.28.615444.|Cancers (Basel). 2022 Mar 19;14(6):1575.|Cell Chem Biol. 2018 Feb 15;25(2):135-142.e5.|Cell Chem Biol. 2019 Aug 15;26(8):1067-1080.e8. |Cell Mol Life Sci. 2020 May 21.|Cell Rep. 2020 Apr 28;31(4):107586.|Cell Syst. 2018 Apr 25;6(4):424-443.e7.|Cell. 2021 Apr 15;184(8):2167-2182.e22.|Clin Cancer Res. 2020 Apr 15;26(8):2011-2021. |EMBO Rep. 2022 Apr 11;e53932.|Free University of Berlin. Gedruckt mit Genehmigung des Fachbereichs Veterinärmedizin. 2021 Mar.|Harvard Medical School LINCS LIBRARY|Int J Biol Sci. 2023 Aug 6;19(13):4123-4138.|iScience. 2024 May 16.|J Med Chem. 2021 Mar 11;64(5):2725-2738.|Molecules. 2023 Mar 4.|Nature. 2024 Apr;628(8007):408-415.|PLoS Genet. 2024 Jun 3;20(6):e1011308.|Purdue University. Department of Chemistry.|Research Square Preprint. 2022 Jan.|Research Square Preprint. 2024 Apr 2.|School of Medicine, Department of Pharmacology. 2020 Jun.|Sci Data. 2024 Sep 19.|Sci Rep. 2015 Dec 1;5:17675. |Sci Rep. 2021 Mar 8;11(1):5374.|Sci Rep. 2024 Oct 31;14(1):26239.|Sci Transl Med. 2018 Jul 18;10(450):eaaq1093.|The University of Chicago. Biological Sciences Division Pritzker School of Medicine. 2022 Aug.|Toxicol Lett. 2024 Sep 12:S0378-4274(24)02025-3.|Turk Neurosurg. 2016;26(6):922-929.|Cancer Discov. 2021 Oct 6;candisc.1848.2020.|Cell Commun Signal. 2022 Sep 5;20(1):96.|Proc Natl Acad Sci U S A. 2021 Nov 16;118(46):e2115667118.|Research Square Preprint. 2024 May 2.